Net Cash Provided by (Used in) Financing Activities of IMMUCELL CORP /DE/ from 31 Dec 2010 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
IMMUCELL CORP /DE/ quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Mar 2025.
  • IMMUCELL CORP /DE/ Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $403,647, a 10% decline year-over-year.
  • IMMUCELL CORP /DE/ annual Net Cash Provided by (Used in) Financing Activities for 2024 was $2,882,813, a 65% increase from 2023.
  • IMMUCELL CORP /DE/ annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1,751,454, a 57% increase from 2022.
  • IMMUCELL CORP /DE/ annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1,114,239, a 71% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

IMMUCELL CORP /DE/ Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $403,647 -$37,104 -10% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $366,543 -$1,115,167 -149% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $748,624 -$1,041,005 -58% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $1,789,629 +$1,966,054 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $176,425 -$217,558 -529% 01 Jan 2021 31 Mar 2021 10-Q/A 21 Nov 2022 2022 Q1
Q1 2020 $41,133 -$7,548,004 -99% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q1 2019 $7,589,137 +$7,358,165 +3186% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q1 2018 $230,972 -$24,947 -9.7% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
Q1 2017 $255,919 -$4,986,997 -95% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1
Q1 2016 $5,242,916 +$5,286,723 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1
Q1 2015 $43,807 -$167 -0.38% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2016 2016 Q1
Q1 2014 $43,640 +$993 +2.2% 01 Jan 2014 31 Mar 2014 10-Q 12 May 2015 2015 Q1
Q1 2013 $44,633 -$59,792 -394% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014 2014 Q1
Q1 2012 $15,159 -$563,906 -97% 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013 2013 Q1
Q1 2011 $579,065 01 Jan 2011 31 Mar 2011 10-Q 14 May 2012 2012 Q1

IMMUCELL CORP /DE/ Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,882,813 +$1,131,359 +65% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $1,751,454 +$637,215 +57% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2022 $1,114,239 -$2,764,481 -71% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $3,878,720 +$1,967,715 +103% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023 2022 FY
2020 $1,911,005 -$5,031,087 -72% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2019 $6,942,092 +$6,052,477 +680% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
2018 $889,615 -$8,856,566 -91% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020 2019 FY
2017 $9,746,181 +$1,422,634 +17% 01 Jan 2017 31 Dec 2017 10-K 22 Mar 2019 2018 FY
2016 $8,323,547 +$5,881,509 +241% 01 Jan 2016 31 Dec 2016 10-K 29 Mar 2018 2017 FY
2015 $2,442,038 +$2,629,201 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
2014 $187,163 -$27,866 -17% 01 Jan 2014 31 Dec 2014 10-K 25 Mar 2016 2015 FY
2013 $159,297 -$44,505 -39% 01 Jan 2013 31 Dec 2013 10-K 25 Mar 2016 2015 FY
2012 $114,792 -$729,373 -119% 01 Jan 2012 31 Dec 2012 10-K 26 Mar 2015 2014 FY
2011 $614,581 -$351,074 -36% 01 Jan 2011 31 Dec 2011 10-K 28 Mar 2013 2012 FY
2010 $965,655 01 Jan 2010 31 Dec 2010 10-K 28 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.